Overall survival in cancer drug trials as a new surrogate end point for overall survival in the real world Journal Article
| Authors: | Mailankody, S.; Prasad, V. |
| Article Title: | Overall survival in cancer drug trials as a new surrogate end point for overall survival in the real world |
| Keywords: | sorafenib; outcomes; advanced hepatocellular-carcinoma |
| Journal Title: | JAMA Oncology |
| Volume: | 3 |
| Issue: | 7 |
| ISSN: | 2374-2437 |
| Publisher: | American Medical Association |
| Date Published: | 2017-07-01 |
| Start Page: | 889 |
| End Page: | 890 |
| Language: | English |
| ACCESSION: | WOS:000405533400005 |
| DOI: | 10.1001/jamaoncol.2016.5296 |
| PROVIDER: | wos |
| PUBMED: | 27892992 |
| Notes: | Editorial Material -- Source: Wos |
